General Catalyst leads $20M funding round for company digitizing clinical trials

Venture capital firm General Catalyst led a $20 million funding round for Faro Health, a cloud-computing company working on digitizing clinical trials.

Advertisement

Faro’s platform works to provide insights to medical professionals building clinical trials, according to a Feb. 9 Fero news release.

“Faro has developed software that allows rapid evaluation of clinical study costs, accessibility to patients and ease of study conduct,” Elena Viboch, partner at General Catalyst, said in the release. “By helping study teams answer complex questions, Faro’s solution aims to improve lives by bringing more efficiency to clinical trials.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Released OR time is leaving capacity — and revenue — on the table

Wednesday, July 22
1:00 PM - 2:00 PM CDT

Presenters: Kelly Connolly, MHSA, PMPJane Yang, MHACaity Butler, MSN, RN, CNORThomas Brehmer

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.